Cabaletta Bio (CABA) Capital Expenditures (2019 - 2025)
Cabaletta Bio's Capital Expenditures was $205,000 in Q4 2025, down 45.5% from $376,000 a year earlier but up 162.8% from the prior quarter.
Powered by 
Analysis
Cabaletta Bio (CABA) Capital Expenditures (2019 - 2025) Analysis & Trends
For FY2025, Capital Expenditures at Cabaletta Bio came in at $1.23 million, down 44.4% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $2.21 million in FY2024 (+221.8%), $687,000 in FY2023 (-72.0%), $2.45 million in FY2022 (+110.4%) and $1.17 million in FY2021 (+83.6%).
- Quarterly Capital Expenditures has moved between $57,000 (Q2 2023) and $1.09 million (Q3 2022) over five years.
- Compared with a year earlier, Capital Expenditures has declined for four straight quarters, with growth averaging 44.2% over the last seven quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q3 2024 (growth of 289.2%); the worst was Q3 2023 (a decline of 94.0%).
- Per Business Quant data, CABA's Capital Expenditures in the three quarters before Q4 2025 was $78,000 (Q3 2025), $161,000 (Q2 2025) and $785,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Cabaletta Bio | 339.09 Mn | 339.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 785,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Sep 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 770,000.00 |
| Mar 31, 2024 | 812,000.00 |
| Dec 31, 2023 | 185,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 316,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 898,000.00 |
| Mar 31, 2022 | 147,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 530,000.00 |
| Jun 30, 2021 | 388,000.00 |
| Mar 31, 2021 | 97,000.00 |
API Access
Cabaletta Bio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();